Sphingosine kinase inhibitor suppresses IL-18-induced interferon-gamma production through inhibition of p38 MAPK activation in human NK cells

Biochem Biophys Res Commun. 2008 Sep 12;374(1):74-8. doi: 10.1016/j.bbrc.2008.06.091. Epub 2008 Jul 3.

Abstract

Natural killer (NK) cells play an important role in the innate immune response. Interleukin-18 (IL-18) is a well-known interferon-gamma (IFN-gamma inducing factor, which stimulates immune response in NK and T cells. Sphingosine kinase (SPHK) catalyzes the formation of sphingosine 1-phosphate (S1P), which acts as a second messenger to function as an anti-apoptotic factor and proliferation stimulator of immune cells. In this study, to elucidate whether SPHK is involved in IL-18-induced IFN-gamma production, we measured IL-18-induced IFN-gamma production after pre-treatment with SPHK inhibitor (SKI) in NK-92MI cells. We found that IL-18-induced IFN-gamma expression was blocked by SKI pre-treatment in both mRNA and protein levels. In addition, the increased IFN-gamma production by stimulation with IL-18 is mediated through both SPHK and p38 MAPK. To determine the upstream signals of SKI and p38 MAPK in IL-18-induced IFN-gamma production, phosphorylation levels of p38 MAPK was measured after SKI pre-treatment. As a result, inhibition of SPHK by SKI blocked phosphorylation of p38 MAPK, showing that SPHK activation by IL-18 is an upstream signal of p38 MAPK activation. Inhibition of SPHK by SKI also inhibited IL-18-induced IFN-gamma production in human primary NK cells. In conclusion, SPHK activation is an essential factor for IL-18-induced IFN-gamma production via p38 MAPK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Enzyme Activation / drug effects
  • Humans
  • Interferon-gamma / antagonists & inhibitors*
  • Interferon-gamma / biosynthesis
  • Interleukin-18 / pharmacology
  • Interleukin-18 / physiology*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Lysophospholipids / biosynthesis
  • Phosphorylation / drug effects
  • Phosphotransferases (Alcohol Group Acceptor) / antagonists & inhibitors
  • Phosphotransferases (Alcohol Group Acceptor) / genetics
  • Phosphotransferases (Alcohol Group Acceptor) / physiology*
  • Protein Kinase Inhibitors / pharmacology
  • Sphingosine / analogs & derivatives
  • Sphingosine / biosynthesis
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors

Substances

  • Interleukin-18
  • Lysophospholipids
  • Protein Kinase Inhibitors
  • sphingosine 1-phosphate
  • Interferon-gamma
  • Phosphotransferases (Alcohol Group Acceptor)
  • sphingosine kinase
  • p38 Mitogen-Activated Protein Kinases
  • Sphingosine